Perspective Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Perspective Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q2 2024.
  • Perspective Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 67.4M shares, a 76% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 67.4M -213M -76% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 587M +308M +111% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 28.2M -114M -80.2% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 281M +138M +97.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 280M +138M +97.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 279M +137M +96.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 142M +72.5K +0.05% Dec 31, 2022 10-K 2024-03-28
Q3 2022 142M +198K +0.14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 142M +125K +0.09% Jun 30, 2022 10-KT 2023-05-01
Q1 2022 142M +575K +0.41% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 142M +54.8M +62.8% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 142M +73M +106% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 142M +73M +106% Jun 30, 2021 10-KT 2023-05-01
Q1 2021 141M +73.8M +109% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 87.2M +19.8M +29.4% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 68.9M +1.51M +2.24% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 68.9M +1.51M +2.24% Jun 30, 2020 10-K 2021-09-27
Q1 2020 67.7M +313K +0.46% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 67.4M +56.9K +0.09% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 67.4M +56.9K +0.09% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 67.4M +11.1M +19.6% Jun 30, 2019 10-K 2020-09-25
Q1 2019 67.3M +12.2M +22.2% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 67.3M +12.2M +22.2% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 67.3M +12.3M +22.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 56.3M +1.31M +2.39% Jun 30, 2018 10-K 2019-09-27
Q1 2018 55.1M +82.8K +0.15% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 55.1M +82.8K +0.15% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 55M +6.8K +0.01% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 55M +6.8K +0.01% Jun 30, 2017 10-K 2018-09-26
Q1 2017 55M +6.8K +0.01% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 55M +3.87K +0.01% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 55M -2.93K -0.01% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 55M +43.1K +0.08% Jun 30, 2016 10-K 2017-09-28
Q1 2016 55M +127K +0.23% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 55M +130K +0.24% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 55M +130K +0.24% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 55M +266K +0.49% Jun 30, 2015 10-K 2016-09-09
Q1 2015 54.9M +702K +1.3% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 54.9M +16.5M +42.9% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 54.9M +16.5M +42.9% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 54.7M +20.1M +58% Jun 30, 2014 10-K 2015-09-14
Q1 2014 54.2M +19.6M +56.5% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 38.4M +3.81M +11% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 38.4M +3.82M +11% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 34.6M +3.67M +11.9% Jun 30, 2013 10-K 2014-09-29
Q1 2013 34.6M +5.3M +18.1% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 34.6M +5.3M +18.1% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 34.6M +8.1M +30.6% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 31M +4.51M +17% Jun 30, 2012 10-K 2013-09-30
Q1 2012 29.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 29.3M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 26.5M Sep 30, 2011 10-Q/A 2011-12-13
Q2 2011 26.4M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.